2型心肌梗死患者的冠状动脉与心脏疾病:前瞻性队列研究
该前瞻性队列研究筛查8064例肌钙蛋白升高患者,纳入100例初步诊断为2型心肌梗死的患者,均接受冠状动脉和心脏影像学检查。结果显示68%存在冠状动脉疾病,42%有梗死模式延迟钆增强或节段性室壁运动异常,34%有左心室收缩功能障碍,多数既往未识别且未接受循证治疗。
要点
- 2型心梗患者中68%存在冠状动脉疾病,30%为梗阻性。
- 42%有梗死模式延迟钆增强或节段性室壁运动异常,34%有左心室收缩功能障碍。
- 多数冠状动脉疾病和左心室收缩功能障碍既往未识别且未接受循证治疗。
核心结论
- 对2型心肌梗死患者进行系统冠状动脉和心脏影像学检查,可识别三分之二患者的冠状动脉疾病和三分之一患者的左心室收缩功能障碍。
- 大多数2型心肌梗死患者存在未识别和未治疗的冠状动脉或心脏疾病,为启动循证治疗提供了机会。
研究设计与样本
- 前瞻性队列研究,筛查8064例连续肌钙蛋白升高患者,纳入100例初步诊断为2型心肌梗死且无衰弱、肾或肝衰竭的患者。
- 所有参与者接受冠状动脉影像(有创或CT血管造影)和心脏影像(磁共振或超声心动图),病因独立裁定。
主要发现
- 100例患者中位年龄65岁(IQR 55-74),43%为女性;影像学重新分类7例:5例为1型或4b型心肌梗死,2例为急性心肌损伤。
- 2型心肌梗死患者就诊时中位肌钙蛋白I为195 ng/L(IQR 62-760),重复检测为1165 ng/L(IQR 277-3782)。
- 冠状动脉疾病患病率68%(63/93),其中梗阻性30%(28/93)。
- 梗死模式延迟钆增强或节段性室壁运动异常见于42%(39/93),左心室收缩功能障碍见于34%(32/93)。
- 仅10例患者冠状动脉和心脏影像均正常;冠状动脉疾病和左心室收缩功能障碍既往未识别分别占60%(38/63)和84%(27/32),仅33%(21/63)和19%(6/32)接受循证治疗。
临床怎么用
- 对2型心肌梗死患者应考虑系统冠状动脉和心脏影像学检查,以识别可治疗的冠状动脉疾病和左心室收缩功能障碍。
- 影像学发现常为既往未识别且未治疗,应启动循证治疗以改善临床结局。
局限性
- 研究排除了衰弱、肾或肝衰竭患者,结果可能不适用于这些人群。
- 样本量较小(100例),需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 myocardial infarction is caused by myocardial oxygen supply-demand imbalance, and its diagnosis is increasingly common with the advent of high-sensitivity cardiac troponin assays. Although this diagnosis is associated with poor outcomes, widespread uncertainty and confusion remain among clinicians as to how to investigate and manage this heterogeneous group of patients with type 2 myocardial infarction. METHODS: In a prospective cohort study, 8064 consecutive patients with increased cardiac troponin concentrations were screened to identify patients with type 2 myocardial infarction. We excluded patients with frailty or renal or hepatic failure. All study participants underwent coronary (invasive or computed tomography angiography) and cardiac (magnetic resonance or echocardiography) imaging, and the underlying causes of infarction were independently adjudicated. The primary outcome was the prevalence of coronary artery disease. RESULTS: In 100 patients with a provisional diagnosis of type 2 myocardial infarction (median age, 65 years [interquartile range, 55-74 years]; 43% women), coronary and cardiac imaging reclassified the diagnosis in 7 patients: type 1 or 4b myocardial infarction in 5 and acute myocardial injury in 2 patients. In those with type 2 myocardial infarction, median cardiac troponin I concentrations were 195 ng/L (interquartile range, 62-760 ng/L) at presentation and 1165 ng/L (interquartile range, 277-3782 ng/L) on repeat testing. The prevalence of coronary artery disease was 68% (63 of 93), which was obstructive in 30% (28 of 93). Infarct-pattern late gadolinium enhancement or regional wall motion abnormalities were observed in 42% (39 of 93), and left ventricular systolic dysfunction was seen in 34% (32 of 93). Only 10 patients had both normal coronary and normal cardiac imaging. Coronary artery disease and left ventricular systolic dysfunction were previously unrecognized in 60% (38 of 63) and 84% (27 of 32), respectively, with only 33% (21 of 63) and 19% (6 of 32) on evidence-based treatments. CONCLUSIONS: Systematic coronary and cardiac imaging of patients with type 2 myocardial infarction identified coronary artery disease in two-thirds and left ventricular systolic dysfunction in one-third of patients. Unrecognized and untreated coronary or cardiac disease is seen in most patients with type 2 myocardial infarction, presenting opportunities for initiation of evidence-based treatments with major potential to improve clinical outcomes. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT03338504.
引用
- Bularga, Hung, Daghem, et al. Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study. Circulation. 2022. PMID: 35341327. doi:10.1161/CIRCULATIONAHA.121.058542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。